AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

863.024

-10.542-1.21%

Number of Gainers:6

Number of Losers:13

Number of Flat:13

PE:- -

High:867.567

Open:866.474

Low:858.835

Close:873.566

Volume:29.59M

Turnover:350.22M

Market Cap:222.52B

Float Cap:172.62B

Loading ...

Mesoblast Limited to Host Half-Year Financial Results Webcast

Australian shares ease after record run; banks anchor weekly advance

Assessing Ansell’s Valuation After Strong Half Year 2025 Earnings Dividend Hike And Completed Buyback

Simply Wall St.

Mesoblast (ASX:MSB) Valuation In Focus As Ryoncil Data And New Trial Plan Signal Clinical Momentum

Simply Wall St.

Should Regulatory Scrutiny of Pricing and Legal Challenges Require Action From Woolworths Group (ASX:WOW) Investors?

Simply Wall St.

Assessing American Tower’s Valuation As Analyst Support And Institutional Buying Increase

Simply Wall St.

Woolworths Says Co Now 100% Powered by Renewable Electricity Across Australia, NZ

MT Newswires Live

CSL Ltd-Change of Director's Interest Notice

THOMSON REUTERS

Woolworths Group (ASX:WOW) Valuation In Focus As Half Year Results And Legal Issues Approach

Simply Wall St.

Assessing 3M (MMM) Valuation After Mixed Momentum And A 6% Undervalued Fair Value Estimate

Simply Wall St.

BUZZ-Australia's Healius drops on bigger-than-expected half-year loss

BUZZ-IDT Australia eyes strongest session in over four years as EBITDA loss narrows

BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly

Healius Posts Narrower Fiscal H1 Underlying Loss, Higher Revenue

MT Newswires Live

Starpharma H1 Net Income AUD 1.4 Million

THOMSON REUTERS

BRIEF-CSL And Lilly Enter Licensing Agreement For Clazakizumab

Healius H1 Revenue Continuing Operations AUD 688.1 Million

THOMSON REUTERS

CSL Ltd - CSL Will Receive an Upfront Payment of $100 Mln

THOMSON REUTERS

CSL Ltd - Exclusive Licensing Agreement Granting Certain Rights to Develop and Commercialise Clazakizumab

THOMSON REUTERS

Despite Micro-X's Pullback, Insiders Still Gained AU$20k

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7501/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":863.0238,"timestamp":1771563599923,"preClose":873.5655,"halted":0,"volume":29587455,"delay":0,"changeRate":-0.012067,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-10.541687,"latestTime":"02-20 16:00:00 AEDT","open":866.47424,"high":867.56726,"low":858.8351,"amount":350223967,"amplitude":0.009996,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771801200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1771542000000,1771563600000]],"turnoverRate":0.002061,"increases":3,"decrements":13,"flats":16,"marketCap":222515129906.25,"floatMarketCap":172620823544.83594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":867.56726,"amplitude":0.009996,"preClose":873.5655,"low":858.8351,"latestPrice":863.0238,"volume":29587455,"delay":0,"open":866.47424,"prevYearClose":900.1661,"prevWeekClose":858.915,"prevMonthClose":933.794,"prevQuarterClose":900.166,"fiveDayClose":858.915,"twentyDayClose":921.099,"sixtyDayClose":925.334,"secType":"PLATE","market":"AU","turnoverRate":0.002061,"marketCap":222515129906.25,"floatMarketCap":172620823544.83594,"timestamp":1771563599923,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":6,"down":13,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612340261","title":"Mesoblast Limited to Host Half-Year Financial Results Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2612340261","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612340261?lang=en_us&edition=fundamental","pubTime":"2026-02-20 20:00","pubTimestamp":1771588846,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via GlobeNewswire  on February 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL5qVvJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014039.USD","LU2210150020.SGD","SG9999014013.SGD","MSB.AU","BK7508","IE00B3QW5Z07.USD","BK4585","SG9999014005.SGD","BK7067","LU0314104364.USD","IE00BKPKM429.USD","LU2095319765.USD","BK4112","IE00BGHQF748.EUR","BK7501","NDAQ"],"gpt_icon":0},{"id":"2612251683","title":"Australian shares ease after record run; banks anchor weekly advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2612251683","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612251683?lang=en_us&edition=fundamental","pubTime":"2026-02-20 14:10","pubTimestamp":1771567843,"startTime":"0","endTime":"0","summary":"Australian shares ease after record run; banks anchor weekly advanceUpdates to closeASX 200 ends the week 1.8% higherRio down 3.1% after flat annual resultsGuzman y Gomez hits record lowBy Kumar Tanishk. Feb 20  - Australian shares ended a few pips lower on Friday but extended weekly gains, supported by strong corporate earnings, with banks cushioning losses on the day.The S&P/ASX 200 .AXJO slipped 4.8 points to 9,081.4, snapping a four-day winning streak, but rose 1.8% for the week after touching a record 9,118.3 on Thursday.Markets have rallied on solid earnings from BHP BHP.AX and National Australia Bank NAB.AX, with investors now looking to results from Woodside Energy WDS.AX, Woolworths WOW.AX, Coles COL.AX and Qantas QAN.AX.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nL4N3ZG067:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","LU1046248800.SGD","LU0898667661.SGD","BK7501","LU0161305163.EUR","LU0971552673.USD","LU0505663152.USD","LU0345777147.USD","LU0345777659.USD","LU0788109121.HKD","IE00BWDBJ516.SGD","LU0612318385.USD","BK7507","LU0572940350.SGD","LU0612318971.USD","NAB.AU","LU1130305938.SGD","LU0345781412.USD","LU1302929846.USD","IE0034235071.USD","LU0266512473.USD","GYG.AU","BK7142","LU1309081286.SGD","LU2463526074.USD","LU0264606111.USD","RIO.UK","BK7030","LU0330918003.SGD","BHP.AU","WDS.AU","LU0345780950.USD","BK7137","LU0955669360.SGD","BK7040","IE00B3M56506.USD","IE00BQJZX424.USD","LU0654597011.USD","QBE.AU","BK5111","LU1023059493.AUD","SG9999002521.SGD","SUN.AU","WOW.AU","SG9999001143.SGD","LU0171293334.USD","QAN.AU","BK7034","LU0011963245.USD","BK7135"],"gpt_icon":0},{"id":"2612287162","title":"Assessing Ansell’s Valuation After Strong Half Year 2025 Earnings Dividend Hike And Completed Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2612287162","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612287162?lang=en_us&edition=fundamental","pubTime":"2026-02-20 00:29","pubTimestamp":1771518542,"startTime":"0","endTime":"0","summary":"Ansell (ASX:ANN) has just reported half year 2025 results, with net income of US$88.8 million and basic EPS from continuing operations of US$0.615, along with a higher interim dividend and a completed A$47.2 million buyback.\nSee our latest analysis for Ansell.\nAt a share price of A$33.51, Ansell’s 1-day and 7-day share price returns of 1.70% and 3.59% suggest a short term lift in sentiment. However, the 90-day share price return of 6.50% and 1-year total shareholder return of 5.04% both point...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/assessing-ansells-valuation-after-strong-half-year-2025-earn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/assessing-ansells-valuation-after-strong-half-year-2025-earn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7126","ANN.AU","BK7501"],"gpt_icon":0},{"id":"2612286639","title":"Mesoblast (ASX:MSB) Valuation In Focus As Ryoncil Data And New Trial Plan Signal Clinical Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2612286639","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612286639?lang=en_us&edition=fundamental","pubTime":"2026-02-19 19:21","pubTimestamp":1771500069,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) has presented new clinical data for Ryoncil to transplant specialists, reporting consistently high survival outcomes in steroid refractory acute graft versus host disease across multiple patient groups.\nSee our latest analysis for Mesoblast.\nThe latest Ryoncil data arrives after a mixed price run, with Mesoblast’s 90 day share price return of 4.76% contrasting with a 12.64% decline year to date and a three year total shareholder return of 164.49%. This suggests long term...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-in-focus-as-ryoncil-data-and-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-in-focus-as-ryoncil-data-and-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK7501","MSB","MSB.AU","BK4006","BK7067"],"gpt_icon":0},{"id":"2612286673","title":"Should Regulatory Scrutiny of Pricing and Legal Challenges Require Action From Woolworths Group (ASX:WOW) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2612286673","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612286673?lang=en_us&edition=fundamental","pubTime":"2026-02-19 19:18","pubTimestamp":1771499934,"startTime":"0","endTime":"0","summary":"In recent days, Woolworths Group has come under increased scrutiny ahead of its late-February half-year results, with attention on food retail performance, margin trends, operational upgrades, and ongoing legal challenges in Australia. \nThis combination of operational efficiency initiatives, pricing scrutiny, and regulatory actions is shaping how investors reassess Woolworths’ role within the Australian retail sector. \nWe’ll now examine how regulatory scrutiny over pricing claims and related...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/874687-main-header/1585186851010","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/874687-main-header/1585186851010"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-retailing/asx-wow/woolworths-group-shares/news/should-regulatory-scrutiny-of-pricing-and-legal-challenges-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-retailing/asx-wow/woolworths-group-shares/news/should-regulatory-scrutiny-of-pricing-and-legal-challenges-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7040","BK4211","ISBC","BK7501","BK4100","WOW","BK7511","WOW.AU"],"gpt_icon":0},{"id":"2612724454","title":"Assessing American Tower’s Valuation As Analyst Support And Institutional Buying Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2612724454","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612724454?lang=en_us&edition=fundamental","pubTime":"2026-02-19 13:37","pubTimestamp":1771479448,"startTime":"0","endTime":"0","summary":"Analyst support and institutional buying put American Tower in focus\nAmerican Tower (AMT) has moved into the spotlight after a recent stretch of gains that coincided with strong analyst buy ratings and increased positions from institutions such as Aberdeen Group plc and CIBC World Markets.\nSee our latest analysis for American Tower.\nThat six day winning streak, which added roughly 13% to the share price before the recent 3.35% one day pullback to US$186.62, sits alongside a 6.76% year to date...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/assessing-american-towers-valuation-as-analyst-support-and-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/assessing-american-towers-valuation-as-analyst-support-and-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AMT","AMT.AU","BK4554","BK7007","BK4219","DCF","BK4585","BK4588","BK4581","BK4084","BK7501","BK4534"],"gpt_icon":0},{"id":"2612718554","title":"Woolworths Says Co Now 100% Powered by Renewable Electricity Across Australia, NZ","url":"https://stock-news.laohu8.com/highlight/detail?id=2612718554","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612718554?lang=en_us&edition=fundamental","pubTime":"2026-02-19 12:34","pubTimestamp":1771475645,"startTime":"0","endTime":"0","summary":"Woolworths Group  said it is now 100% powered by renewable electricity across Australia and New Zealand, according to a Thursday statement.This milestone is projected to deliver a reduction of over 74% in operational emissions, moving Woolworths closer towards its target of a 80% reduction by 2030, the statement said.Woolworths said it sources more than two-thirds of its electricity requirements through partnerships and contracts across Australia and New Zealand through a mix of wind and solar, and its own network of more than 320 on-site solar power systems.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XJO.AU","BK7511","BK7501","XKO.AU","WOW.AU","BK7040"],"gpt_icon":0},{"id":"2612947955","title":"CSL Ltd-Change of Director's Interest Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2612947955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612947955?lang=en_us&edition=fundamental","pubTime":"2026-02-19 11:43","pubTimestamp":1771472595,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUE4LM7YQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7508","BK7511","BK7067","BK7501"],"gpt_icon":0},{"id":"2612119684","title":"Woolworths Group (ASX:WOW) Valuation In Focus As Half Year Results And Legal Issues Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2612119684","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612119684?lang=en_us&edition=fundamental","pubTime":"2026-02-18 14:25","pubTimestamp":1771395926,"startTime":"0","endTime":"0","summary":"Why Woolworths Group is in focus ahead of half year results\nWoolworths Group (ASX:WOW) is back in the spotlight after its share price slipped 0.84% on Friday, with investors gearing up for the half year results due on 25 February.\nThe upcoming numbers matter because the market is watching three things at once: how food sales are holding up, how heavy discounting is affecting margins, and whether guidance changes, all while regulatory and class action issues sit in the background.\nSee our...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/874687-main-header/1585186851010","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/874687-main-header/1585186851010"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-retailing/asx-wow/woolworths-group-shares/news/woolworths-group-asxwow-valuation-in-focus-as-half-year-resu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-retailing/asx-wow/woolworths-group-shares/news/woolworths-group-asxwow-valuation-in-focus-as-half-year-resu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WOW.AU","BK7511","BK4100","BK7501","BK7040","WOW","DCF"],"gpt_icon":0},{"id":"2612413245","title":"Assessing 3M (MMM) Valuation After Mixed Momentum And A 6% Undervalued Fair Value Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2612413245","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612413245?lang=en_us&edition=fundamental","pubTime":"2026-02-18 13:27","pubTimestamp":1771392454,"startTime":"0","endTime":"0","summary":"3M stock at a glance\n3M (MMM) has been drawing attention after recent share price moves, with the stock closing at $167.62 and short term returns mixed across the past week, month, and past 3 months.\nSee our latest analysis for 3M.\nRecent trading has been choppy, with a 1 day share price return of a 2.44% decline and a modest 3.58% share price return year to date. The 1 year total shareholder return of 14.58% and 3 year total shareholder return of just over 2x suggest longer term holders have...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/289194-main-header/1756202868825","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/289194-main-header/1756202868825"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-mmm/3m/news/assessing-3m-mmm-valuation-after-mixed-momentum-and-a-6-unde","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-mmm/3m/news/assessing-3m-mmm-valuation-after-mixed-momentum-and-a-6-unde","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK4585","LU1894683348.USD","BK7040","LU0787776722.HKD","MMM.AU","LU1093756168.USD","BK4533","BK7049","MMM","IE000M9KFDE8.USD","LU0683600562.USD","BK4534","LU1894683264.USD","BK4206","BK4512","BK4588","LU1093756325.SGD","SG9999002232.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2612490465","title":"BUZZ-Australia's Healius drops on bigger-than-expected half-year loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2612490465","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612490465?lang=en_us&edition=fundamental","pubTime":"2026-02-18 12:18","pubTimestamp":1771388330,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Healius drops on bigger-than-expected half-year loss** Shares of Australia's Healius HLS.AX fall 11.4% to A$0.723, their lowest since late August** Healthcare co posts half-year underlying loss after tax of A$11 million ,** HY loss is smaller than the loss recorded a year earlier, but misses the VA consensus estimate of A$2.2 mln ** Jarden notes that although cost reductions have offset corporate costs at face value, it appears to have been swapped out with a step up in one-off termination costs of A$20.8 mln. ** This is well above the brokerage's expectations after co indicated earlier that there would be no further restructuring costs** However, Jarden notes Agilex segment performed better, helped by closure of loss-making toxicology business** Jefferies notes pathology revenue and EBITDA margins increased in HY ** YTD, shares down 13.2% ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL6N3ZE06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","HLS.AU","BK7124","BK7501"],"gpt_icon":0},{"id":"2612490525","title":"BUZZ-IDT Australia eyes strongest session in over four years as EBITDA loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2612490525","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612490525?lang=en_us&edition=fundamental","pubTime":"2026-02-18 11:56","pubTimestamp":1771387013,"startTime":"0","endTime":"0","summary":"BUZZ-IDT Australia eyes strongest session in over four years as EBITDA loss narrows** Shares of IDT Australia IDT.AX rise 22.1% to A$0.0525, on track for strongest session since Nov 2021 if gains hold","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL4N3ZE080:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDT.AU","BK7096","BK7501"],"gpt_icon":0},{"id":"2612491120","title":"BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2612491120","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612491120?lang=en_us&edition=fundamental","pubTime":"2026-02-18 08:32","pubTimestamp":1771374761,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly** Shares of CSL CSL.AX rise 1.5% to A$153.78** Shares rebound after plunging 16.9% last week on posting an 81% drop in firsthalf profit, while CEO Paul McKenzie stepped down** Australian biotech giant signs licensing agreement with Eli Lilly LLY.N, granting it certain rights to develop and commercialise clazakizumab** Clazakizumab is an antibody aimed at preventing heart-related illness and death in people with endstage kidney disease** CSL will receive an upfront payment of $100 million** CSL shares down 10.9% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL6N3ZE00N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837300.USD","SGXZ99366536.SGD","IE00BJJMRX11.SGD","LU1551013342.USD","LU2168563687.JPY","LU2168564495.EUR","LU0787776722.HKD","LU2750360641.GBP","IE00B1XK9C88.USD","IE00BK4W5L77.USD","IE0002141913.USD","IE00B7KXQ091.USD","LU0198837287.USD","LU0943347566.SGD","IE0009355771.USD","LU2491050071.SGD","LU2756315318.SGD","BK7067","SG9999015945.SGD","IE0004445239.USD","LU1868836591.USD","LU2471134952.CNY","LU0672654240.SGD","BK4588","IE00BFSS7M15.SGD","IE00BK4W5M84.HKD","LU1232071149.USD","LU0320765992.SGD","LU1804176565.USD","LU2168564065.EUR","LU2360106947.USD","LU1064131342.USD","LU1267930730.SGD","LU2471134879.HKD","BK4516","IE00BFTCPJ56.SGD","SG9999014898.SGD","LU1974910355.USD","LU0158827948.USD","LU0320765059.SGD","LU0061475181.USD","LU0466842654.USD","BK4585","LU0238689110.USD","LU2357305700.SGD","SG9999015978.USD","IE0005OL40V9.USD","IE00B775H168.HKD","SG9999014906.USD","LU2324357040.USD","LU1057294990.SGD","LU0823434583.USD","LU0432979614.USD","IE00B4JS1V06.HKD","LU2023250330.USD","IE00BFSS8Q28.SGD","LU0471298694.HKD","IE00BJLML261.HKD","LU2750360997.AUD","LU2461242641.AUD","LU0354030511.USD","LU2023250504.SGD","SGXZ57979304.SGD","LU0786609619.USD","LU1035775433.USD","CSL.AU","SG9999017495.SGD","LU0820561818.USD","SGXZ81514606.USD","LU0058720904.USD","ELIL","LU0964807845.USD","LU2468319806.SGD","LU2108987350.USD","IE0004445015.USD","LU0683600562.USD","LU2491049909.HKD","BK7511","LU2237438978.USD","LU1983299246.USD","LU0689472784.USD","LU2462157665.USD","LU2746668974.SGD","LU1988902786.USD","LLY","LU2023251221.USD","SGXZ31699556.SGD","IE00BJJMRZ35.SGD","LU2756315664.SGD","LU2063271972.USD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU1917777945.USD","SGXZ51526630.SGD","LU0109394709.USD","LU1323610961.USD","LU1127390331.HKD","SG9999013999.USD","LU0079474960.USD","LU0471298777.SGD","LU1868836757.USD","LU0109391861.USD","BK4581","LU1145028129.USD","LU2089284900.SGD","BK7508","LU2213496289.HKD","LU0289739699.SGD","LU0316494557.USD","LU0353189680.USD","LU2237443895.HKD","IE00B2B36J28.USD","SG9999018857.SGD","LU1291159041.SGD","LU1023059063.AUD","LU1868837136.USD","LU2211815571.USD","LU2602419157.SGD","LU2111349929.HKD","LU0417517546.SGD","LU0820561909.HKD","BK4534","LU0882574139.USD","BK4007","BK7501","LU0096364046.USD","LU2237443382.USD","LU2168564222.USD","ELIS","LU1814569148.SGD","LU2087625088.SGD","LU2106854487.HKD","LU0256863811.USD","LU0385154629.USD","LU1069344957.HKD","LU2491050154.USD","IE00BJT1NW94.SGD","LU2552382058.USD","LU0203202063.USD","LU0820562030.AUD","LU1061106388.HKD","LU0203201768.USD","LU2237443465.HKD","LU0122379950.USD","LU0823434740.USD","LU2361044865.SGD","LU2746668461.USD","SG9999018865.SGD","LU0225283273.USD","LU1720051108.HKD","LU2456880835.USD","LU1712237335.SGD","IE00BWXC8680.SGD","LU2896262040.SGD","LU0210536198.USD","LU2237443622.USD","LU2471134523.USD","LU2237443978.SGD","LU1720051017.SGD","IE00BN29S564.USD","LU2271345857.HKD","LU0823416689.USD","LU2237443549.SGD","LU2361044949.HKD","LU2236285917.USD","LU2471134796.USD","LU2264538146.SGD","LU0097036916.USD","LU0456855351.SGD","BK4533","SG9999014914.USD","LU2552382215.SGD","SG9999014880.SGD","LU0882574055.USD","SG9999001176.SGD","LU0114720955.EUR","GB00BDT5M118.USD","LU1551013425.SGD","LU2112291526.USD","LU0889565916.HKD","LU2028103732.USD","SG9999015952.SGD","LU2265009873.SGD","LU0640476718.USD","IE00BKDWB100.SGD","LLYZ","LU2168564149.EUR","LU0106261372.USD","LU0708995401.HKD","SG9999015986.USD","LU1280957306.USD","LU1629891620.HKD","LU0006306889.USD","LU0353189763.USD","LU1623119135.USD","SG9999001176.USD","LU0094547139.USD","LU2089283258.USD","LU2417539215.USD","LU0266013472.USD","LU2552382132.HKD","IE00BJJMRY28.SGD","LU2361045086.USD","LU2089984988.USD","LU0256863902.USD","LLYX","LU1989771016.USD","LU1366192091.USD","LU1093756325.SGD","LU0158827781.USD","LU1093756168.USD","LU0234572021.USD","IE00BKPKM429.USD","LU0354030438.USD","BK4599","LU1548497426.USD","LU1868836914.USD"],"gpt_icon":1},{"id":"2612049968","title":"Healius Posts Narrower Fiscal H1 Underlying Loss, Higher Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2612049968","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612049968?lang=en_us&edition=fundamental","pubTime":"2026-02-18 07:29","pubTimestamp":1771370983,"startTime":"0","endTime":"0","summary":"Healius  reported on Wednesday a fiscal first-half underlying loss of AU$0.015 per share, compared with a AU$0.028 loss per share a year earlier.Analysts polled by FactSet expected a loss of AU$0.01.Revenue from continuing operations for the six months ended Dec. 31, 2025, was AU$688.1 million, compared with AU$662.3 million a year earlier. Analysts surveyed by FactSet expected AU$687 million.The company expects fiscal 2026 earnings to align with current consensus estimates and anticipates achieving high single-digit earnings before interest and taxes margins by June 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","BK7509","HLS.AU","BK7501"],"gpt_icon":0},{"id":"2612938444","title":"Starpharma H1 Net Income AUD 1.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2612938444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612938444?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:38","pubTimestamp":1771364288,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nPLXC4FBF4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","SPL.AU","BK7096"],"gpt_icon":0},{"id":"2612498320","title":"BRIEF-CSL And Lilly Enter Licensing Agreement For Clazakizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2612498320","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612498320?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:19","pubTimestamp":1771363186,"startTime":"0","endTime":"0","summary":"BRIEF-CSL And Lilly Enter Licensing Agreement For ClazakizumabFeb 18 (Reuters) - CSL Ltd CSL.AX:CSL AND LILLY ENTER LICENSING AGREEMENT FOR CLAZAKIZUMABEXCLUSIVE LICENSING AGREEMENT GRANTING CERTAIN R","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0DO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1127390331.HKD","LU1548497426.USD","LU0061475181.USD","LU0456855351.SGD","IE00BK4W5L77.USD","LU1989771016.USD","IE00B775H168.HKD","LU1974910355.USD","LU2471134952.CNY","LU0114720955.EUR","LU1983299246.USD","SG9999018865.SGD","LU2089283258.USD","LU2213496289.HKD","LU0354030438.USD","LU2168564065.EUR","IE00B1BXHZ80.USD","LU2023251221.USD","BK4516","LU2552382215.SGD","LU0882574139.USD","LU1868836591.USD","LU0432979614.USD","LU0943347566.SGD","LU1551013342.USD","LU2491049909.HKD","SGXZ57979304.SGD","LU0471298777.SGD","LU1267930730.SGD","LU0823416689.USD","LU2471134523.USD","LU2471134879.HKD","SGXZ51526630.SGD","LU2756315664.SGD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2168564222.USD","IE00BWXC8680.SGD","LU0158827781.USD","LU1323610961.USD","LU0820562030.AUD","LU2237443465.HKD","LU1366192091.USD","LU0203201768.USD","SGXZ99366536.SGD","IE00BKPKM429.USD","LU0006306889.USD","LU2462157665.USD","LU0058720904.USD","LU0109391861.USD","LU2237438978.USD","BK7067","LU2750360641.GBP","IE00B2B36J28.USD","LU2023250504.SGD","LU1720051017.SGD","LU0786609619.USD","SG9999018857.SGD","LU0210536198.USD","LU0289739699.SGD","LU2360106947.USD","SG9999014880.SGD","LU0094547139.USD","LU0106261372.USD","LU2089284900.SGD","LU2361044949.HKD","LU2417539215.USD","LU2357305700.SGD","LU2265009873.SGD","IE0005OL40V9.USD","LU0079474960.USD","LU1814569148.SGD","LU1868837136.USD","LU2237443549.SGD","LU0234572021.USD","SGXZ81514606.USD","LU0225283273.USD","LU1623119135.USD","IE00B1XK9C88.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","IE00BFSS7M15.SGD","LU0320765059.SGD","LU2168564495.EUR","LU2211815571.USD","LU2456880835.USD","BK4585","IE0004445239.USD","LU0238689110.USD","LU2106854487.HKD","LU2361045086.USD","SGXZ31699556.SGD","LU2236285917.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","LU2237443382.USD","LU0708995401.HKD","LU2491050071.SGD","IE00BKDWB100.SGD","LU0320765992.SGD","BK4581","BK7511","LU2552382132.HKD","LU2746668461.USD","LU0820561818.USD","BK7508","LU0122379950.USD","SG9999015986.USD","IE0002141913.USD","IE00BJJMRX11.SGD","LU0203202063.USD","LU1093756325.SGD","BK4534","LU0353189763.USD","LU1551013425.SGD","ELIL","LU2112291526.USD","LU1093756168.USD","LU2087625088.SGD","LU0823434740.USD","LU1868836757.USD","LU0353189680.USD","LU1232071149.USD","SG9999001176.SGD","BK4588","LU1804176565.USD","LU1868837300.USD","LU2461242641.AUD","LU2361044865.SGD","IE00BFTCPJ56.SGD","LU2168563687.JPY","LU1720051108.HKD","BK7501","LU1145028129.USD","LU2111349929.HKD","SG9999015952.SGD","LU0417517546.SGD","SG9999014898.SGD","LU0256863811.USD","SG9999014914.USD","LU0097036916.USD","LU2750360997.AUD","SG9999014906.USD","SG9999017495.SGD","LU2324357040.USD","SG9999015945.SGD","LLY","IE00B7KXQ091.USD","LU2896262040.SGD","LLYZ","LU1064131342.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","CSL.AU","IE00B4JS1V06.HKD","LU0683600562.USD","LU2168564149.EUR","LU0672654240.SGD","LU1280957306.USD","LU2237443978.SGD","BK4007","LU1917777945.USD","LU0354030511.USD","LU0787776722.HKD","SG9999001176.USD","LU2552382058.USD","BK4533","LU0266013472.USD","LU0466842654.USD","LU2602419157.SGD","LU1057294990.SGD","SG9999015978.USD","LU1629891620.HKD","LU1023059063.AUD","LU1712237335.SGD","IE00BK4W5M84.HKD","LU0316494557.USD","LU2028103732.USD","LU1035775433.USD","LU2023250330.USD","LU2756315318.SGD","LU2237443622.USD","LU2108987350.USD","LU2271345857.HKD","IE00BJJMRY28.SGD","LU2746668974.SGD","LU0323591593.USD","LU1988902786.USD","LU0256863902.USD","LU2264538146.SGD","LU2237443895.HKD","LU0964807845.USD","LU2491050154.USD","LU2468319806.SGD","LU0471298694.HKD","LU0198837287.USD","LU0823434583.USD","LU0096364046.USD","LU0882574055.USD","GB00BDT5M118.USD","BK4599","LU0385154629.USD","LU0689472784.USD","LLYX","LU0820561909.HKD","LU0889565916.HKD","LU0640476718.USD","LU1069344957.HKD","LU2063271972.USD","IE0004445015.USD","LU0158827948.USD","LU2471134796.USD","ELIS","IE00BJLML261.HKD","IE00BN29S564.USD"],"gpt_icon":1},{"id":"2612460073","title":"Healius H1 Revenue Continuing Operations AUD 688.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460073?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:18","pubTimestamp":1771363126,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nPLX86871B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","BK7509","HLS.AU","BK7501"],"gpt_icon":0},{"id":"2612460444","title":"CSL Ltd -  CSL Will Receive an Upfront Payment of $100 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460444?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:13","pubTimestamp":1771362816,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0DO:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","CSL.AU","BK7508","BK7511"],"gpt_icon":0},{"id":"2612415460","title":"CSL Ltd - Exclusive Licensing Agreement Granting Certain Rights to Develop and Commercialise Clazakizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2612415460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612415460?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:13","pubTimestamp":1771362816,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0DO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","CSL.AU","BK7501","BK7511"],"gpt_icon":0},{"id":"2612467368","title":"Despite Micro-X's Pullback, Insiders Still Gained AU$20k","url":"https://stock-news.laohu8.com/highlight/detail?id=2612467368","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612467368?lang=en_us&edition=fundamental","pubTime":"2026-02-18 04:02","pubTimestamp":1771358555,"startTime":"0","endTime":"0","summary":"Insiders who purchased Micro-X Limited ( ASX:MX1 ) shares in the past 12 months are unlikely to be deeply impacted by...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-mx1/micro-x-shares/news/despite-micro-xs-pullback-insiders-still-gained-au20k","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-mx1/micro-x-shares/news/despite-micro-xs-pullback-insiders-still-gained-au20k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","BK7501","MX1.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":102,"code":"91000000","status":"200"}]}}